Headquarters: San Diego, California, United States
Trade prices
Volume:
Market Cap:6.14B
Prev closed:48.69
Open:46.37
High:48.5
Low:44.83
52 week low:12.71
52 week high:51.3
Dividends:No Dividends
Next ER:May 9, 2023 After Market Closes
Top Stories (HALO)
About the Company
Halozyme Therapeutics is a U.S. biotechnology company that develops novel oncology therapies designed to target the tumor microenvironment and licenses a novel drug delivery technology through corporate partnerships.
The company was founded in 1998 and went public in 2004.
Talk about Halozyme Therapeutics Inc below in comments section below.
Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.
While many books explain the how of bitcoin, The Internet of Money delves into the why of bitcoin. Acclaimed information-security expert and author of Mastering Bitcoin, Andreas M. Antonopoulos examines and contextualizes the significance of bitcoin through a series of essays spanning the exhilarating maturation of this technology.
